SMD Rise PCL

SMD Rise PCL EBIT Margin

The EBIT Margin (Operating Margin) of SMD Rise PCL (SMD100.BK) as of Oct 20, 2026 is 2.73 %. In the previous year, EBIT Margin (Operating Margin) was 8.45 % — a change of -67.72% (lower).

EBIT Margin

2.73 %

YoY

-67.72%

Last updated:

EBIT Margin (Operating Margin) of SMD Rise PCL is 2025 2.73 % . EBIT Margin (Operating Margin) of SMD Rise PCL was 2024 8.45 % . It decreases by -67.72% lower compared to the previous year.

SMD Rise PCL's operating (EBIT) margin stands at 2.7%, down from 25.6% several years earlier.

The SMD Rise PCL EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2018
10.89 THB
Jan 1, 2019
13.76 THB
Jan 1, 2020
15.98 THB
Jan 1, 2021
25.62 THB
Jan 1, 2022
18.81 THB
Jan 1, 2023
11.28 THB
Jan 1, 2024
8.45 THB
Jan 1, 2025
2.73 THB
The SMD Rise PCL EBIT Margin history
YEAREBIT MarginYoY
2.73 %-67.72%
8.45 %-25.11%
11.28 %-40.02%
18.81 %-26.58%
25.62 %+60.38%
15.98 %+16.08%
13.76 %+26.42%
10.89 %-15.33%
12.86 %-11.99%
14.61 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

SMD Rise PCL Stock analysis

What does SMD Rise PCL do? SMD Rise PCL, listed on the Stock Exchange of Thailand with ticker SMD100.BK and ISIN THA320A10Y01, operates in the Health Care sector. The company was founded through an IPO on June 17, 2021. SMD Rise PCL is engaged in the distribution of medical devices and equipment, focusing on the import and distribution of medical supplies and services for medical equipment. The company specializes in respiratory system-related medical equipment, particularly offering sleep monitoring services and counseling on the use of positive pressure air compressors (CPAP) for treating obstructive sleep apnea (OSA). Its services target patients with sleep disorders, including snoring, obstructive sleep apnea, insomnia, and other conditions such as excessive daytime sleepiness, sleepwalking, bruxism, and leg twitching. Additionally, the company provides support for patients with high blood pressure, diabetes, and obesity. SMD Rise PCL's subsidiary is Saint Medical Trading Co., Ltd. The company's website is https://www.saintmed.com/. SMD Rise PCL is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SMD Rise PCL stock

EBIT Margin (Operating Margin) of SMD Rise PCL is 2.73 % in 2025.

EBIT Margin (Operating Margin) of SMD Rise PCL changed from 8.45 % to 2.73 %, representing a -67.72% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) SMD Rise PCL since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s SMD Rise PCL with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — SMD Rise PCL

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — SMD Rise PCL